Ledaga® 160 micrograms/g gel
Ledaga, INN- chlormethine
1 Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety Lugano, Switzerlan
Helsinn Healthcare SA signs exclusive license agreement with Juniper Biologics Pte. Ltd. for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
Chlormethine Gel (Ledaga) - NCBI Bookshelf
LTC-MF
Acuerdo con Recordati por Ledaga® en Argentina. by P3DESIGN - Issuu
Chlormethin|Ledaga®|86|2019 | PZ – Pharmazeutische Zeitung
Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports | SpringerLink
Diapositiva 1
Ledaga, INN- chlormethine
Main points Therapeutic strategy Clinical data
View of Chlormethine Gel (Ledaga) | Canadian Journal of Health Technologies
LTC-MF
Aangemeld voor het onderzoek | Kanker.nl
Untitled
Lymphomes T cutanés
Actelion gets EU Approval to Launch a Treatment for a Rare Skin Cancer | Biopharma Business
Ledaga, INN- chlormethine
Ledaga recommended by NICE for rare type of lymphoma - PharmaTimes
Helsinn Group, Actelion Pharma Enter Agreement | Contract Pharma
Deelname onderzoek MF Ledaga | Kanker.nl
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region) - Assaf - 2022 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
Ledaga Consumer Information – English
Ledaga Consumer Information – English
